NIH-funded research NIH-funded research

Support for regulatory activities in clinical research

Official title: Regulatory Affairs Support

Funded at Technical Resources International, INC. · NIH-11113761 · Data updated 2026-11-12

This study is all about helping make sure that clinical research is done the right way, so new treatments can get to patients faster and more safely.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionTechnical Resources International, INC.
NIH-funded
Lab location1 site (Bethesda, United States)
Project startJuly 1, 2022
Project endJune 30, 2025
Funding year2024
Award (this year)$3,751,811
NIH project number75N93022C00010-P00004-9999-1
Project IDNIH-11113761 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals involved in or affected by clinical trials related to infectious diseases.

Less likely to help

Patients who are not involved in clinical trials or those with conditions outside the focus of NIAID's research may not receive direct benefits from this research.

What this research studies

This research focuses on providing essential support for regulatory affairs related to clinical research conducted by the National Institute of Allergy and Infectious Diseases (NIAID). It involves offering scientific, technical, and project management assistance to ensure that clinical studies comply with regulatory standards. By streamlining these processes, the research aims to facilitate the advancement of clinical trials and improve the efficiency of bringing new treatments to patients. Patients may benefit indirectly through enhanced regulatory support that leads to more effective clinical research outcomes.

Why it matters

Potential benefit: If successful, this research could lead to faster and more efficient development of new treatments for patients.

How similar studies have gone: While this research supports ongoing clinical activities, similar regulatory support initiatives have shown success in enhancing the efficiency of clinical trials.

Where this research is happening

  • Technical Resources International, INC.
    Bethesda, United States
    Active

Researchers

  • Principal investigator: Heredia, Elizabeth — Technical Resources International, INC.
  • Study coordinator: Heredia, Elizabeth

Related research

Other NIH-funded projects on the same topics.

  • Support for research on antibiotic resistance

    This program is here to help researchers find better ways to fight infections that don't respond to antibiotics by providing support, training, and making sure everything is done safely and correctly.

    NIH research Technical Resources International, INC. · Bethesda, United States · NIH-11304137

  • Support for clinical research operations and management

    This study is all about making clinical trials better and safer for patients by providing researchers with the support and training they need, so you can feel confident that the research is being done right and could lead to better treatments for you.

    NIH research Technical Resources International, INC. · Bethesda, United States · NIH-11304136

  • Improving data collection for HIV and HPV prevention trials in the Americas

    This study is working to make it easier and more reliable to gather and manage information from clinical trials that help prevent HIV and HPV, so that people in the US, Latin America, and the Caribbean can participate more easily and effectively in these important health studies.

    NIH research Technical Resources International, INC. · Bethesda, United States · NIH-11216361

  • Support for developing new cancer drugs and therapies

    This study is all about helping to create new cancer treatments by making sure everything is done right and safely during the testing process, so that patients can get better options for their care.

    NIH research Technical Resources International, INC. · Bethesda, United States · NIH-11110272

  • Evaluating immune modulator drugs for COVID-19 treatment in hospitalized adults

    This study is looking at how well three different immune system drugs work for treating COVID-19 by collecting and analyzing samples from adults in the hospital, and your participation could help us understand their safety and benefits for patients like you.

    NIH research Technical Resources International, INC. · Bethesda, United States · NIH-10722555

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.